A new study from the University of Arizona suggests that compounds found in the cannabis plant may offer powerful pain relief without producing the psychoactive “high” linked to THC. The findings could open the door to safer treatments for chronic pain conditions like fibromyalgia and post-surgical recovery.
ALSO READ: Best Proverb of the Day: “People visit the rich with gifts, but they visit the poor with...”
Cannabis aroma compounds show unexpected medical potential
Researchers focused on terpenes, natural compounds responsible for the smell and flavor of many plants, including Cannabis sativa. While these molecules are often associated with aroma, the study found they may also play a major role in pain relief.
Four terpenes were tested:
Geraniol
Linalool
Beta-caryophyllene
Alpha-humulene
In preclinical mouse models, all four showed pain-relieving effects, with geraniol producing the strongest response.
Relief without the high
Unlike THC, terpenes do not produce intoxicating effects, making them a promising alternative for medical research. These compounds may provide therapeutic benefits without the psychoactive impact commonly associated with cannabis use, the research shows.
Researchers tested their effects on two difficult-to-treat conditions:
Fibromyalgia pain
Post-surgical pain
Both are known for being complex and hard to manage with existing medications.
Strong results in fibromyalgia and post-surgery models
Fibromyalgia affects millions worldwide and is often resistant to standard pain treatments. Post-surgical pain, meanwhile, sits between acute and chronic pain and can trigger long-lasting sensitivity in the nervous system.
The study found meaningful pain reduction in both cases.
Researchers explained: "Our research is showing that terpenes are not a good option for reducing acute pain resulting from an injury, such as stubbing your toe or touching a hot stove; however, we are seeing significant reductions in pain when terpenes are used for chronic or pathological pain," said Streicher. "This study was the first to investigate the impact of terpenes in preclinical models of fibromyalgia and post-operative pain and expand the scope of potential pain-relieving treatments using terpenes."
Why scientists are excited about terpenes
According to the research team, the most promising outcome is the possibility of a non-opioid, plant-based pain treatment.
They also point out a major healthcare gap:
Fibromyalgia affects up to 5% of the global population
About 4 million adults in the U.S. are estimated to live with the condition
Roughly 310 million surgeries are performed worldwide each year
That creates a strong demand for safer, more effective pain management options.
How the compounds may work in the body
The study suggests the pain-relieving effects may involve the adenosine A2a receptor, which is also linked to caffeine’s biological activity. Researchers believe this pathway could explain both the pain relief and possible sedative effects observed in earlier studies, though more research is needed.
Expert perspective on natural drug discovery
The researchers emphasize that plants—and nature in general—remain a major source of potential medicines still waiting to be discovered.
As highlighted in the study:
"The research that is being done by Dr. Streicher's lab on terpenes and their potential to help those who suffer from chronic pain demonstrates the importance of basic research. There are hundreds of unique chemicals that plants make, including the Cannabis plant, that are undiscovered," Vanderah said.
"Nature is incredible at making unique chemical structures, and many of these chemicals are unknowns when it comes to their abilities to aid in human health, diseases and disorders. A great current example is medication semaglutide, sold under the brand name Ozempic, which has a chemical structure that was isolated not from a plant, but from an animal that is prevalent in the Southwest, the Gila monster. These discoveries from natural products through research such as Dr. Streicher's can result in very useful medications."
Researchers say the next step is to better understand how these terpenes behave in the human body and whether they can be developed into safe, effective treatments.
While the current findings are based on animal models, the early results suggest a promising new direction in pain research—one that could reduce reliance on opioids and improve quality of life for chronic pain patients.
